- Home
- USA vs SLNO Comparison
USA vs SLNO Comparison
Compare USA & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USA
- SLNO
- Stock Information
- Founded
- USA 1986
- SLNO 1999
- Country
- USA United States
- SLNO United States
- Employees
- USA N/A
- SLNO N/A
- Industry
- USA Finance Companies
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- USA Finance
- SLNO Health Care
- Exchange
- USA Nasdaq
- SLNO Nasdaq
- Market Cap
- USA 1.9B
- SLNO 3.8B
- IPO Year
- USA N/A
- SLNO 2014
- Fundamental
- Price
- USA $6.49
- SLNO $51.76
- Analyst Decision
- USA
- SLNO Strong Buy
- Analyst Count
- USA 0
- SLNO 10
- Target Price
- USA N/A
- SLNO $112.50
- AVG Volume (30 Days)
- USA 880.5K
- SLNO 1.7M
- Earning Date
- USA 01-01-0001
- SLNO 11-05-2025
- Dividend Yield
- USA 9.66%
- SLNO N/A
- EPS Growth
- USA N/A
- SLNO N/A
- EPS
- USA N/A
- SLNO N/A
- Revenue
- USA N/A
- SLNO $32,656,999.00
- Revenue This Year
- USA N/A
- SLNO N/A
- Revenue Next Year
- USA N/A
- SLNO $175.39
- P/E Ratio
- USA N/A
- SLNO N/A
- Revenue Growth
- USA N/A
- SLNO N/A
- 52 Week Low
- USA $5.62
- SLNO $41.50
- 52 Week High
- USA $7.09
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- USA 40.76
- SLNO 27.03
- Support Level
- USA $6.46
- SLNO $48.91
- Resistance Level
- USA $6.60
- SLNO $72.99
- Average True Range (ATR)
- USA 0.07
- SLNO 4.25
- MACD
- USA -0.01
- SLNO -1.48
- Stochastic Oscillator
- USA 13.89
- SLNO 11.83
About USA Liberty All-Star Equity Fund
Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.